The COVID-19 pandemic has caused the Company to take measures to modify its business practices.The future development of these new products will require a significant amount of spending over the next few years before any significant, robust sales will be realized.The Company sells some products through third parties, including third-party sales intermediaries and value-added resellers.The Company’ s efforts to comply with such laws and regulations are time consuming and costly.Unfavorable industry conditions could have a material adverse effect on the Company’ s results of operations or financial condition.Any such changes could have a material adverse effect on the financial statements of the Company.Actual results for all estimates could differ materially from the estimates and assumptions used, which could have a material adverse effect on our financial condition and results of operations.The analytical instrument market may also, from time to time, experience low sales growth.The Company’ s success also depends on its ability to execute leadership succession plans.The demand for the Company’ s products is dependent upon the size of the markets for its LC, LC-MS, thermal analysis, rheometry and calorimetry products; the timing and level of capital spending and expenditures of the Company’ s customers; changes in governmental regulations, particularly those affecting drug, food and drinking water testing; funding available to academic, governmental and research institutions; general economic conditions and the rate of economic growth in the Company’ s major markets; and competitive considerations.Such transactions involve numerous risks, including difficulties in integrating the acquired operations, technologies and products; diversion of management’ s attention from other business concerns; inability to predict financial results; potential departures of key employees of the acquired company; and difficulties in effectively transferring divested businesses and liabilities.Even if the Company can do so, it cannot be sure that these acquisitions will have a positive impact on the Company’ s business or operating results.The Company manufactures LC instruments at facilities in Milford, Massachusetts and through a subcontractor in Singapore; precision chemistry separation columns at its facilities in Taunton, Massachusetts and Wexford, Ireland; MS products at its facilities in Wilmslow, England, Solihull, England and Wexford, Ireland; thermal analysis and rheometry products at its facilities in New Castle, Delaware; and other instruments and consumables at various other locations as a result of the Company’ s acquisitions.Failure to adequately protect intellectual property could have materially adverse effects on the Company’ s results of operations or financial condition.Most of the raw materials, components and supplies purchased by the Company are available from a number of different suppliers; however, a number of items are purchased from limited or single sources of supply.A prolonged inability to obtain these components or modules could have an adverse effect on the Company’ s financial condition or results of operations.32 Table of Contents Operating income increased 27% in 2021 as compared to 2020.The sales growth in 2021 for each customer class was driven by the increased demand as our customers returned to pre-pandemic levels of operations.The Company’ s products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic and government customers.COVID-19 Pandemic Both the Company’ s domestic and international operations have been and continue to be affected by the ongoing global COVID-19 pandemic that has led to volatility and uncertainty in the U. S. and international markets.Wyatt Technology is a pioneer in innovative light scattering and field-flow fractionation instruments, software, accessories and services.This CDMS technology makes it possible to analyze extremely large proteins and protein complexes used in cell and gene therapies that would otherwise be difficult to analyze with conventional mass spectrometry.Wyatt Technology is a pioneer in innovative light scattering and field-flow fractionation instruments, software, accessories and services.On an ongoing basis, the Company evaluates its policies and estimates.Actual amounts may differ from these estimates under different assumptions or conditions.If actual future demand or market conditions are less favorable than those projected by management, additional write-downs may be required.These arrangements often require upfront payments and may include additional milestone or royalty payments, contingent upon certain future events.